Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367767 · ClinicalTrials.gov registry record
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 709
- Enrollment target
NCT03367767: Completed study, sponsored by National Eye Institute (NEI).
NCT03367767 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 709 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03367767 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 709 participants
- Enrollment target
Study Summary
Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies followed the natural course of the diseases. They also provided data on the long-term effects of certain oral supplements on AMD. Objective: To study the long-term effects of oral supplements on several things. These include incidences of lung cancer, development of late AMD, cataract surgery, cognitive function, and cardiovascular events. Eligibility: Former AREDS2 and AREDS2 Follow-On participants Design: Participants will have 1 visit. It will include: An eye exam that tests how well participants can see, measures eye pressure, and checks eye movements. The pupil will be dilated with eye drops. Pictures will be taken of the retina and the inside of the eye. Participants will grip a device in their hand to measure their grip strength. A blood sample will be taken. This will be stored for future genetic research. Cells may be created from the sample. A small sample of skin will be taken. Sponsoring Institution: National Eye Institute
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 709 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2019-03-21 |
What the finished NCT03367767 record still lists
NCT03367767 is an observational study that tracks outcomes without assigning an intervention. The registered 709 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03367767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03367767 about?
NCT03367767 is a clinical study titled "Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On". Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies followed the natural course of the diseases. They also provided data on the long-term effects of certa...
What is the current status of trial NCT03367767?
This trial is currently completed. The enrollment target is 709 participants. The study started on 2018-05-23. Estimated completion is 2019-03-21.
Who is sponsoring clinical trial NCT03367767?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI